Release
📈 Stocks
Roche Secures Exclusive Global Rights to Rona Therapeutics' ALK7 RNAi Therapy
(2 days ago)
Roche expands its metabolic portfolio through a global licensing deal with Rona Therapeutics for an ALK7-targeting RNAi candidate, marking a significant validation…